Search

everythinglearnresearchcommunity

for

Search:↓

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Plant-based compounds can improve wound dressings and skin medication delivery.

Advanced human skin models improve drug development and could replace animal testing.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

New understanding and treatments for hair loss are improving, but more research is needed.

Skin reactions from cancer treatments might predict how well the treatments work.

New treatments for hair loss could involve using stem cells and a process called the Wnt/beta-catenin pathway to stimulate hair growth.

Keratin mutations cause skin diseases and could lead to new treatments.

Bioinspired polymers are promising for advanced medical treatments and tissue repair.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Identified genes linked to male-pattern baldness may help develop new treatments.

People with HIV and low T cell counts have more hair and scalp problems.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Skin stem cells interacting with their environment is crucial for maintaining and regenerating skin and hair, and understanding this can help develop new treatments for skin and hair disorders.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.